CVE-2010-3523
Unspecified vulnerability in the PeopleSoft Enterprise PeopleTools component in Oracle PeopleSoft...
Unspecified vulnerability in the PeopleSoft Enterprise PeopleTools component in Oracle PeopleSoft and JDEdwards Suite 8.49.28 and 8.50.12 allows remote attackers to affect integrity via unknown vectors.
Exploit likelihood
What each source reports
NVD Score used
Unspecified vulnerability in the PeopleSoft Enterprise PeopleTools component in Oracle PeopleSoft and JDEdwards Suite 8.49.28 and 8.50.12 allows remote attackers to affect integrity via unknown vectors.
- Record
CVE-2010-3523- CVSS 2.0
- 5.0 Medium
AV:N/AC:L/Au:N/C:N/I:P/A:N - Updated
- 2026-11-02
CVE List No score
Unspecified vulnerability in the PeopleSoft Enterprise PeopleTools component in Oracle PeopleSoft and JDEdwards Suite 8.49.28 and 8.50.12 allows remote attackers to affect integrity via unknown vectors.
- Record
CVE-2010-3523- Updated
- 2026-11-02
EUVDEUVD-2010-3519 No score
Unspecified vulnerability in the PeopleSoft Enterprise PeopleTools component in Oracle PeopleSoft and JDEdwards Suite 8.49.28 and 8.50.12 allows remote attackers to affect integrity via unknown vectors.
- Record
EUVD-2010-3519- Updated
- 2026-11-03
GitHub AdvisoriesGHSA-39x8-9c9m-275r No score
Unspecified vulnerability in the PeopleSoft Enterprise PeopleTools component in Oracle PeopleSoft...
Unspecified vulnerability in the PeopleSoft Enterprise PeopleTools component in Oracle PeopleSoft and JDEdwards Suite 8.49.28 and 8.50.12 allows remote attackers to affect integrity via unknown vectors.
- Record
GHSA-39x8-9c9m-275r- Updated
- 2026-11-02
Affected products
History
| Recorded | Changed | Sources |
|---|---|---|
| aliases | EUVD | |
| first indexed | CVE List, GitHub Advisories, NVD |
Dates are when Every CVE recorded each change. Upstream dates may differ.
In short
CVE-2010-3523 is a medium vulnerability (CVSS 5.0) in Oracle Peoplesoft And Jdedwards Product Suite, published October 14, 2010. No source lists public exploit code. EPSS puts the chance of exploitation in the next 30 days at 1.10%, the 65th percentile. No source names a fixed version.